0001237899-13-000043.txt : 20130612
0001237899-13-000043.hdr.sgml : 20130612
20130612091525
ACCESSION NUMBER: 0001237899-13-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130610
FILED AS OF DATE: 20130612
DATE AS OF CHANGE: 20130612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER CHARLES A
CENTRAL INDEX KEY: 0001225470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13907981
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-06-10
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225470
BAKER CHARLES A
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2013-06-10
4
M
0
15000.0
15.8
A
24000
D
Common Stock
2013-06-10
4
S
0
4150.0
250.06
D
19850
D
Common Stock
2013-06-10
4
S
0
3938.0
251.67
D
15912
D
Common Stock
2013-06-10
4
S
0
4748.0
252.32
D
11164
D
Common Stock
2013-06-10
4
S
0
908.0
253.5
D
10256
D
Common Stock
2013-06-10
4
S
0
756.0
254.1
D
9500
D
Common Stock
2013-06-10
4
S
0
200.0
255.16
D
9300
D
Common Stock
2013-06-10
4
S
0
300.0
257.99
D
9000
D
Common Stock
590
I
by Partnership
Non-Qualified Stock Option (right to buy)
15.8
2013-06-10
4
M
0
15000.0
D
2016-01-03
Common Stock
15000
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,150 shares of Company stock on June 10, 2013 at prices ranging from $250.00 to $250.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 3,938 shares of Company stock on June 10, 2013 at prices ranging from $251.15 to $251.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 4,748 shares of Company stock on June 10, 2013 at prices ranging from $252.00 to $252.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 908 shares of Company stock on June 10, 2013 at prices ranging from $253.11 to $253.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 756 shares of Company stock on June 10, 2013 at prices ranging from $254.04 to $254.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on June 10, 2013 at prices ranging from $257.98 to $257.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Charles A. Baker
2013-06-11